About
Small Molecules, Monoclonals
Areas of Focus
Categories
Biologics & BiopharmaceuticalSmall Molecule PharmaceuticalAntibody
Clinical Trials (4)
View allTotal Trials
4
As Lead Sponsor
3
As Collaborator
1
Total Enrollment
466
By Phase
PHASE1/PHASE2: 2NA: 1PHASE2: 1
By Status
COMPLETED: 2RECRUITING: 1TERMINATED: 1
Clinical Trials Pipeline4 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
2027
2028
Today
Hover over trial bars to see details
Recent Trials
NCT05205330Lead Sponsor
Vorbipiprant (CR6086) / Balstilimab (AGEN2034) Combination in Stage IV Refractory pMMR - MSS CRC, and Other Metastatic GI Cancers
PHASE1/PHASE2Recruiting
107 participants
Started: Nov 23, 2021 · Completed: Jun 30, 2027
NCT04788459Collaborator
Safety and Immunogenicity of COVID-eVax, a Candidate Plasmid DNA Vaccine for COVID-19, in Healthy Adult Volunteers
PHASE1/PHASE2Terminated
68 participants
Started: Feb 25, 2021 · Completed: Dec 7, 2021
NCT04693104Lead Sponsor
Intra-articular PVA Hydrogel in Knee Osteoarthritis
NACompleted
43 participants
Started: Oct 1, 2019 · Completed: May 20, 2020
NCT03163966Lead Sponsor
A Study of the EP4 Antagonist CR6086 in Combination With Methotrexate, in DMARD-naïve Patients With Early Rheumatoid Arthritis
PHASE2Completed
248 participants
Started: Oct 5, 2017 · Completed: Jan 8, 2019
Locations (1)
Headquarters
Monza, Italy
Map
Loading map...